Atrys Health, S.A. (BME:ATRY)
Spain · Delayed Price · Currency is EUR 2.675
-0.020 (-0.74%)
May 18, 2026, 4:13 PM CET
Atrys Health Market Cap
Atrys Health has a market cap or net worth of €204.57 million as of May 18, 2026. Its market cap has decreased by -8.66% in one year.
Market Cap
204.57M
Enterprise Value
448.95M
Revenue
144.31M
Ranking
n/a
PE Ratio
n/a
Stock Price
€2.68
Market Cap Chart
Since July 22, 2016, Atrys Health's market cap has increased from 17.85M to 204.57M, an increase of 1,046.35%. That is a compound annual growth rate of 28.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 15, 2026 | 204.57M | -7.98% |
| Dec 31, 2025 | 222.31M | -13.13% |
| Dec 31, 2024 | 255.91M | -8.07% |
| Dec 29, 2023 | 278.37M | -39.03% |
| Dec 30, 2022 | 456.55M | -26.48% |
| Dec 30, 2021 | 620.95M | 107.99% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Jul 22, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Grifols | 5.57B |
| Laboratorios Farmaceuticos Rovi | 3.02B |
| Almirall | 2.43B |
| Pharma Mar | 1.67B |
| Clínica Baviera | 893.83M |
| Prim, S.A. | 221.18M |
| Laboratorio Reig Jofre | 220.63M |
| Oryzon Genomics | 218.12M |